Myalgic Encephalomyelitis - A Disease Looking for Respect

RDR Staff
Published Online: Tuesday, Mar 05, 2013

Myalgic encephalomyelitis (ME) is a condition with unknown origin and unclear treatment options. Widespread inflammation and multisystemic neuropathology seem to be at the core of its pathophysiology.

ME is also commonly referred to as chronic fatigue syndrome but advocates for the condition prefer the ME nomenclature. Chronic fatigue syndrome has been often misused and/or over-diagnosed in the past so it is currently unclear if ME is a rare condition. A recent prevalence study (Vincent et al 2012)  had the estimated number of patients in the U.S. at around the 200,000 mark but more studies are needed to ascertain its true prevalence.

In this interview with Rare Disease Report, patient - and patient advocate - Charlotte von Salis describes ME and the need for more awareness and funding for this condition.

For more information about this ME, visit www.name-us.org

Reference

Vincent A, Brimmer DJ, Whipple MO, et al. Prevalence, incidence, and classification of chronic fatigue syndrome in Olmsted Country, Minnesota, as estimated using the Rochester epidemiology project. Mayo Clinic Proc.2012; 87(12):1145-52

Related Articles
Jason Bobe of the Icahn School of Medicine talks about the need for more people in society - not just patients - to participate in research.
Holly Prigerson PhD, director of the Center for Research on End of Life Care at Weill Cornell Medical College studies end of life care and in this interview she notes that the most expensive and intrusive care may not be the best care.
In this interview with rare disease and sickle cell anemia advocate, Bill Cummings, he discusses why certain outcomes remain popular for regulatory review.
Recently, we talked with Holly Prigerson, PhD, director of the Center for Research on End of Life Care at Weill Cornell Medical College about the studies she has conducted examining end of life care in patients with terminal cancer.
External Resources

MJH Associates
AJMC
Cure
HCPLive
OncLive
Pharmacy Times
Specialty Pharmacy Times
Physicians' Education Resource
Internal Resources

Medicine
Advocacy
Business/Regulratory
Events
Conferences
Connect With Us:

About Us
Advertise
Careers
Contact Us
Privacy Policy
Sponsor
Terms and Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Rare Disease Report 2015
Intellisphere, LLC. All Rights Reserved.